INTRODUCTION
The intestinal microbiota has emerged as a microbial organ, shaped by host genotype, developmental needs, and environmental exposures. Pioneering advances in 16S rRNA sequencing has revealed that two bacterial phyla, Firmicutes and Bacteroidetes, constitute more than 90% of the human microbiome. Despite substantial interpersonal variation in the microbiome in healthy individuals [1, 2] , a core minimal metagenome exists with 3.3 million nonredundant bacterial genes ($150 times the human genome) [3] . These genes are 93% conserved at the enzyme level and play a critical role in secondary carbohydrate metabolism required for energy extraction. To understand the relative contribution of host genotype versus environmental conditions in determining this variation in the human microbiota, adult twinÀtwin and twinÀmother comparisons have been conducted [4] . Notably, the results revealed equivalent differences in dizygotic and monozygotic twinÀ twin comparisons, both of which were more dissimilar than selfÀself comparison, but more similar than twinÀmother comparison, suggesting a key role for environmental cues in shaping the microbiome. Recent studies have revealed how key environmental and microbial exposures functionally shape the mucosal immune system with more pervasive effects on systemic immunity. Mechanistic insights provided by these studies will help identify novel biomarkers and therapeutic strategies for autoimmune diseases. mouse strains as well as numerous inbred mouse strains deficient for immune-linked genes [5] . Notably, alterations occur within several days. Pilot studies in humans have confirmed these findings [6 && ]. In particular, 10 healthy individuals on a stable diet were switched to either plant-based or animalbased diets ad libitum for 5 days. Similarly to the mouse studies, significant changes were seen in the composition and diversity of the microbiota within several days of these dietary changes. These microbial shifts resulted in altered production of short chain fatty acids critical for promoting barrier health and enzymes involved in nutrient extraction. Correlative findings from the microbiota of obese individuals revealed stereotypic reductions in the Bacteroidetes/Firmicutes ratio. When transferred to gnotobiotic (germ-free) mice, these microbiota resulted in an obese phenotype with increased caloric energy extraction from food [7] .
Dietary changes associated with geographic and cultural factors produce characteristic differences in the microbial communities. For example, substantial differences among the geographically distinct communities from the Amazonas of Venezuela, rural Malawi, and U.S metropolitan areas exist, including a stereotypical Bacteroides/Prevotella 'trade-off' in the composition of the intestinal microbiome [8] . Even within individual communities, pronounced differences in the microbiome are seen in infants (<3 years old) compared with adults, reflecting age-associated changes in vitamin and nutrient extraction requirements; for example, the microbiome of breast-fed babies, compared to adults or formula-fed infants, have increased abundance of enzymes involved in de-novo tetrahydrofolate (THF) synthesis. Culturally driven dietary influences also shape the microbiome. Routine consumption of noncaloric artificial sweeteners, for example, lead to key shifts in the microbiome, which, similar to the obese microbiome, can transfer the inflammatory metabolic syndrome phenotype to germ-free mice [9] . This plasticity of the microbiome, driven by dietary factors may, modify an individual's risk for systemic inflammatory disease. Seminal work from Eugene Chang's group illustrated the importance of saturated fat in providing a sulfur-rich environment to support the expansion of the Deltaproteobacteria B. wadsorthia. Coupled with genetic susceptibility for colitis, this expansion of B. wadsorthia resulted in more severe colitis in mouse models [10] . A recent study illustrated the similar potential of two commonly used dietary emulsifiers, carboxymethylcellulose (CMC) and polysorbate 80 (P80). Both CMC and P80 compromise barrier function and leads to microbial population changes that may cause colitis and metabolic syndrome in genetically susceptible animals [11] .
Consistently with the inflammatory potential of distinct microbiota, we recently described the expansion of Prevotella copri in patients with new onset rheumatoid arthritis (NORA) [12] . Notably, Prevotella abundance in these NORA patients inversely correlated with genetic susceptibility conferred by the shared epitope HLA-DRB1, further suggesting a potential role for the microbiome in driving an inflammatory phenotype. A Prevotella-predominant microbiome may also confer susceptibility to inflammatory cardiovascular disease in patients with meat-based diets high in L-carnitine. Metabolism of dietary L-carnitine by the intestinal microbiota results in higher serum trimethylamine-Noxide, which correlates with atherosclerosis in humans and accelerates atherosclerosis in mouse models [13] . A further understanding of these potential biomarkers may guide rational therapeutic use of diet in modulating inflammatory disease.
Additionally, the microbiome may regulate the efficacy of xenobiotic or therapeutic drug intervention for the treatment of autoimmunity. The conversion of digoxin to inactive derivatives by the Actinobacterium Eggerthella lenta provides a classic example of this effect [14] . Transcriptional profiling and comparative genomics using high-throughput sequencing allowed the recent mechanistic discovery of a cytochrome-encoding operon [called cardiac glycoside reductase (cgr)], which regulates digoxin metabolism [15 & ]. Similarly, in NORA, functional analysis of the Prevotella-dominated metagenome revealed a significant decrease in purine metabolic pathways, including tetrahydrofolate reductase, which may have implications for the therapeutic efficacy of methotrexate [12] . Collectively, these recent studies offer insight into the regulation of drug metabolism by the host's microbial organ.
Although dietary interventions may transiently alter the microbiome, emerging data suggest that a window of opportunity exists early in life in
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imprinting the microbiota with lasting effects on the metabolic function of the gut microbial organ. Recent analysis of malnourished twins in both Bangladesh and Malawi revealed that therapeutic intervention with ready-to-use therapeutic food (RUTF) engendered only transient restoration in metabolic function and the gut microbiome of malnourished children, both of which regressed when RUTF was stopped [16,17 && ]. Gnotobiotic mice colonized with fecal communities from malnourished donors lost significantly more weight than mice colonized with fecal communities from the non-malnourished twin, illustrating the potential microbial-dependence of severe malnutrition (Kwashiorkor) in children. In contrast, early life alterations in the microbiome can also support enhanced caloric energy extraction and growth. Indeed, farmers have historically capitalized on the ability to alter long-term metabolic outcomes by feeding low-dose antibiotics to livestock for growth promotion. Recent studies in mice using low-dose penicillin delivered from birth (compared with after weaning) revealed a critical window in development for imprinting a durable microbiome with the propensity for enhanced energy extraction and growth [18 && ]. Thus, in combination with environmental triggers, such as high-fat diets typical of western society, early-life exposure may result in durable effects on the microbiome which predispose toward metabolic and inflammatory disease.
COMMENSAL MICROBIOTA PROMOTE HOMEOSTATIC REGULATION OF IMMUNITY
In addition to modulating metabolic functions, commensal microbiota within the gut microbial organ maintain the delicate balance of immune effectors, which must remain tolerant to innocuous microbial antigen yet poised to protect the host against invasive pathogens. Although a thick mucus layer coating the mucosal surface provides a 'demilitarized zone' to promote segregation [19] , we have proposed two main immune mechanisms for maintaining this balance: homeostatic inhibition and homeostatic induction afforded by mucosal immune cells [20] (Fig. 1) .
Recent evidence revealed the contribution of intestinal mononuclear phagocytes (MNPs) to homeostatic inhibition. Two developmentally distinct classes of CD11b þ CD11c þ MHCII þ MNPs exist in the lamina propria: CD103 þ conventional DCs (cDCs) and the CX 3 CR1 þ MNPs. Historically, CX 3 CR1 þ MNPs were thought not to migrate, but recent data from our laboratory suggest that microbiota actively limits the trafficking of CX 3 CR1 þ MNPs [21 && ]. In the context of antibiotic-induced dysbiosis, CX 3 CR1 þ MNPs can migrate to the mesenteric lymph node and traffic luminal, noninvasive bacteria, resulting in aberrant immunity to commensals. This pathway may contribute to commensal reactivity seen in inflammatory bowel disease (IBD) as well as epitope spreading resulting in aberrant immunity to benign commensal and/or selfantigens. Detailed analysis of these cell populations in response to commensals during steady state as well as inflammation will likely identify targetable pathways in inflammatory disease.
In addition, normal gut microbiota promote homeostatic inhibition by group 3 innate lymphoid cells (ILC3). ILC3 are major producers of Interleukin-22 (IL-22), a key cytokine that acts on epithelial cells to promote healing both in the steady state and during infection [22, 23] . IL-22 also induces antimicrobial peptide production, including the C-type lectins RegIII, by epithelial cells. These antibacterial proteins directly target Gram-positive, but not Gram-negative bacteria, by forming a hexameric membrane-permeabilizing oligomeric pore [24] . Recently, another, albeit indirect, mechanism of ILC3-dependent regulation of luminal bacteria was discovered: epithelial cell fucosylation. These terminal fucose moieties can be cleaved by bacterialderived fucosidases and confer a selective survival advantage to bacteria capable of foraging hostderived carbohydrates, such as Bacteroides thetaiotomicron [25] . Thus, ILC3 maintain homeostatic inhibition by wielding the proverbial carrot and stick (fucosylated carbohydrates and RegIII, respectively) [26] .
How are these bacterial signals sensed by ILC3? During inflammation in both mice [27] and humans [28] , MNPs expand in the lamina propria. Secretion of CXCL16 by the MNPs acts on CXCR6 þ ILC3 to promote co-localization [29] . Early-life microbial exposure, particularly in the neonatal period, may help shape barrier immunity by epigenetically imprinting the Cxcl16 locus [30] . We have recently shown that stimulation of MNPs, but not cDCs, induced the production of IL-23, IL-1b, and the Tumor necrosis factor superfamily member 15 (TNFSF15), which potently augments IL-22 production by ILC3 [28] . In patients with mild-to-moderate colitis (both Crohn's colitis and ulcerative colitis), exposure to the fecal stream increased production of IL-22 by ILC3, implicating the microbiota in this response [28] . Mechanistic understanding of selective and potentially targetable pathways will be critical for therapeutic intervention to promote mucosal healing.
In contrast to innate processes of homeostatic inhibition, commensals are also capable of inducing specific T cell differentiation pathways in the absence of barrier damage, termed homeostatic induction. For example, Clostridium clusters IV and XIVa, isolated from a healthy human donor, induce colonic Foxp3 þ regulatory T cells (T regs ) that produce the anti-inflammatory protein IL-10 [31 & ]. Notably, these strains are decreased in patients with IBD [32] and colonization of germ-free mice with these bacteria attenuated disease models of colitis [31 & ]. Mechanistically, clostridial induction of T regs requires Transforming growth factor-b and high luminal concentration of short chain fatty acidsprimarily butyratethat can induce the differentiation of T regs in vivo and in vitro [33, 34] . The therapeutic efficacy of these microbes in regulating mucosal and systemic inflammation in human will be important to evaluate.
Similarly to the Clostridia, segmented filamentous bacteria (SFB) promote immunity without inducing overt intestinal inflammation. In particular, SFB penetrate the mucus layer and bind tightly to the epithelial surface of the ileum where they induce CD4 þ T helper cells that produce IL-17 and IL-22 (called Th17 cells) [35] . Colonization of mice with SFB can protect against concurrent infectious colitis [35] . In contrast, SFB colonization can also promote systemic Th17 cell activation that supports inflammatory arthritis in the K/BxN mouse model [36] and exacerbates experimental autoimmune encephalomyelitis in mice [37] . The dichotomy of Th17 in promoting barrier protection at the mucosal surface and supporting inflammation systemically may underlie the differential effects of anti-IL-17 therapy seen clinically in psoriasis compared with IBD [38] .
The potential effect of luminal microbes on systemic CD4 þ T cell responses raises the question of cognate antigen specificity of these cells. Although the concept of 'molecular mimicry'cross-activation by sequence similarity in self-antigenat distal sites of inflammation may be consistent with microbial specificity, an alternate theory is that inflammatory microenvironments regulate the quality of effector lymphocyte differentiation independently of cognate antigen [39] . By cloning the T cell receptors (TCRs) of Th17 cells from the small intestine of mice colonized with SFB and expressing them in a hybridoma reporter system, we found that most TCRs were indeed responsive to two immunodominant epitopes in SFB. Confirming the cognate antigen specificity of SFB-induced Th17, co-transfer of cells expressing transgenic TCRs specific for SFB or ovalbumin resulted in Th17 polarization of the SFB transgenic TCRs only [40 & ]. Moreover, concomitant exposure of mice to both SFB and Listeria monocytogenes resulted in Th17 polarization of SFB-specific T cells and Th1 polarization of Listeria-specific T cells, suggesting specificity of the microenvironment and antigen delivery in guiding T cell polarization. As such, genetic insertion of the immunodominant SFB epitope into Listeria resulted in Th1 polarization of SFB-specific T cells. Supplementing these findings, acute infection with Toxoplasma gondii strongly promotes a stereotypic Th1 response and can act in trans to promote noncognate, longlived Th1 memory responses to flagellin antigens expressed by the commensal microbiota [41] . Collectively, these studies reflect distinct interactions of microbiota with the mucosal barrier and/or particular subsets of MNPs in shaping mucosal immunity and systemic autoimmunity.
VIRUSES AND TRANSKINGDOM INTERACTIONS REGULATE IMMUNITY
Enteric viruses are not only a frequent causative agent of human Gastrointestinal disease, but are also active participants in regulating the outcome of commensalism, including host immunity and microbial homeostasis. Recent results using a positive-strand RNA Calicivirus endemic to mouse facilities (called mouse norovirus or MNV) revealed the ability of a single virus to restore the altered intestinal pathology and lymphocyte function associated with either germ-free or antibiotictreated mice [42] . Although the dependence of these findings on the host's innate response to Interferon (IFN)a production reflects a potential key role for co-evolution of eukaryotic viruses with the intestinal immune system of mammals, immune cell activation induced by MNV in the context of genetic susceptibility (for example, mutations in ATG16L associated with IBD) results in aberrant Paneth cell function and increased disease susceptibility.
Similarly reflecting potential co-evolution, recent reports revealed the importance of 'transkingdom interactions' between bacteria and viruses, which have developed systems (both direct and indirect) to regulate each other. Seminal work from Skip Virgin's laboratory has identified the importance of IFN l, a type I interferon, which is induced by commensal microbiota [43] and controls the persistence of MNV [44 & ]. The effect of these signals in the intestine at the steady state or during systemic inflammatory disease will need to be assessed. Reciprocally, viruses likely help shape the bacterial microbiome. Analysis of dsDNA virus-like particles in IBD patient cohorts revealed a significant expansion of Caudovirales bacteriophages, which correlate with significant changes in the bacterial microbiome [45 && ]. Animal models to test the ability of these prokaryotic viruses to regulate the bacterial microbiome in a 'predatorÀprey' fashion during physiology and therapy will be an important area for future investigation.
In addition to bacteria and viruses, helminth colonization of the intestine is frequent, particularly within the developing world. Notable correlations with the ability to control pathogen infection (including M. tuberculosis, HIV, and Plasmodium) have been established, but the mechanism by which they modulate intestinal and systemic immunity is the subject of ongoing research. Recent work identified a key mechanistic role for helminth-mediated induction (Heligomosomoides polygrus and Schistosoma mansoni) of type 2 immunity (predominantly IL-4) to allow a permissive environment for viral reactivation [46] . Similar results hold using another helminth, Trichinella, in blunting the CD8 þ T cell response to coinfection with a mouse norovirus [47] . Notably, these effects depend on the immunomodulatory function of the helminth-derived molecule Ym1 and STAT6-dependent alternative activation of macrophages, but are independent of the microbiota [48] .
DEFINING THE IMMUNE-RELEVANT BACTERIA IN AUTOIMMUNITY
Sequencing technology has revolutionized our understanding of microbiota composition, both in health and disease. The next phase of this revolution is to understand the functional elements of the microbial organ and the ability to target key markers diagnostically and therapeutically. From an autoimmunity perspective, it will be important to understand which of the luminal microbiota are recognized by the host immune system. Analysis of the microbiome recognized by IgA has revealed an enrichment in key microbes with dominant immunological effects in mice, including SFB discussed above [49] . Sentinel species have been identified from IBD patients [49] and malnourished individuals [50] that can dominantly transfer susceptibility to intestinal inflammation in mouse models. Further work is needed to apply these strategies to define the microbes mediating systemic autoimmunity.
CONCLUSION
The gut microbiome constitutes a critical microbial organ with coordinated interactions that shape host immunity. Expanding evidence suggests that a dynamic interaction between microbes and environmental cues (including diet and medicines) exists within the microbial organ that shapes mucosal and systemic immunity. The clinical relevance of a critical developmental window in microbiome development with long-lasting implications for metabolic health will need to be explored in autoimmunity. Key bacteria and viruses provide critical regulation of mucosal and systemic immunity in mouse models, but the identification of immune-relevant bacteria in human autoimmunity will help focus our investigation on the microbial signals driving disease. Emerging research in this field will yield new insights into both diagnostic and therapeutic targets of autoimmunity.
